In this Community Call, we discussed:
- Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
- Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension